Can the ZEVALIN therapeutic regimen be used in elderly patients?
The ZEVALIN therapeutic regimen has been administered in clinical studies to elderly patients aged 65 years and older, including patients aged 75 years and older, for previously untreated and relapsed or refractory follicular NHL.1 • In a randomized study of 414 patients with follicular NHL who had a response to first-line chemotherapy, 206 patients received ZEVALIN. Of these patients 14% (29 patients) were 65 years and over, while 2% (4 patients) were 75 years and older.